Literature DB >> 12153695

Colocalization of CA19-9 and KL-6 to epithelial cells in dilated bronchioles in a patient with idiopathic pulmonary fibrosis complicated by diffuse alveolar damage.

Yuji Shimizu1, Tetsuya Hamada, Yoshiki Tanaka, Atsushi Sasaki, Toshikazu Nemoto.   

Abstract

A 73-year-old woman with idiopathic pulmonary fibrosis (IPF) had an elevated serum CA19-9 level, but not KL-6. Her condition worsened and she subsequently died and this was associated with a rise in the serum KL-6 level. At autopsy, the lung showed a honeycomb appearance macroscopically and, microscopically, hyaline membrane formation was seen. Immunohistochemical staining revealed partial colocalization of KL-6 and CA19-9 to dilated bronchiolar cells. These features suggest that the mechanisms that cause the synthesis and release of CA19-9 and KL-6 from damaged lung tissue in IPF are likely to differ from those in diffuse alveolar damage. In addition, serum KL-6 levels may reflect the severity of disease more sensitively than CA19-9 levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153695     DOI: 10.1046/j.1440-1843.2002.00391.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  8 in total

1.  Serum levels of CA19-9 in patients with nonmalignant respiratory diseases.

Authors:  Takahide Kodama; Hiroaki Satoh; Hiroichi Ishikawa; Morio Ohtsuka
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

2.  Extremely increased serum carbohydrate antigen 19-9 levels caused by new or resistant infections to previous antibiotics in chronic lung diseases.

Authors:  Ji Young Shin; Su Jin Yoo; Bo Mi Park; Sung Su Jung; Ju Ock Kim; Jeong Eun Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-09-30

Review 3.  Serum biomarkers in interstitial lung diseases.

Authors:  Argyris Tzouvelekis; George Kouliatsis; Stavros Anevlavis; Demosthenes Bouros
Journal:  Respir Res       Date:  2005-07-21

4.  Correlation between serum carbohydrate antigen 19-9 levels and computed tomography severity score in patients with nontuberculous mycobacterial pulmonary disease.

Authors:  Kangjoon Kim; Seung Hyun Yong; Su Hwan Lee; Sang Hoon Lee; Ah Young Leem; Song Yee Kim; Kyungsoo Chung; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Hye-Jeong Lee; Young Ae Kang
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

5.  Tumor marker response to SARS-CoV-2 infection among patients with cancer.

Authors:  Alexander H Gunn; Carolyn Tashie; Steven Wolf; Jesse D Troy; Yousuf Zafar
Journal:  Cancer Med       Date:  2022-03-15       Impact factor: 4.711

6.  Normalization of Elevated CA 19-9 Level after Treatment in a Patient with the Nodular Bronchiectatic Form of Mycobacterium abscessus Lung Disease.

Authors:  Boksoon Chang; Seo Goo Han; Wooyoul Kim; Yousang Ko; Junwhi Song; Goohyeon Hong; Jung Seop Eom; Ji Hyun Lee; Byung Woo Jhun; Won-Jung Koh
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-07-31

7.  Correlation of CA19-9 and P57 (KiP2) Expression with Tumor Grade and Invasive Front in Oral Squamous Cell Carcinoma.

Authors:  Fatemeh Mashhadiabbas; Moones Rajabi; Mohammad Javad KharaziFard; Hamidreza Moslemi
Journal:  J Dent (Shiraz)       Date:  2018-12

8.  Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease.

Authors:  Ji Young Hong; Sun Hee Jang; Song Yee Kim; Kyung Soo Chung; Joo Han Song; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Young Ae Kang
Journal:  Braz J Infect Dis       Date:  2015-11-22       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.